skip to content »

Department of Psychiatry - Division of Neuropsychiatry

Houston, Texas

BCM faculty, staff and trainees are the heart of the organization.
Department of Psychiatry - Division of Neuropsychiatry
not shown on screen

Research

Project Title: "Texas TBI Model System of TIRR”
Funding Agency: National Institute on Disability and Rehabilitation Research (NIDRR)
Project Identifier: H133A120020
Description: This project will contribute to the TBI Model Systems (TBIMS) National Database, implement an extensive program of TBI information and consumer education activities, and conduct a local, randomized controlled trial of a novel psychotherapy for emotional distress in persons with TBI.
Principal Investigator/Project Director: Mark Sherer, PhD/Angelle Sander, PhD
Participating Division member: David B. Arciniegas, MD (Co-Investigator/Medical Director)
Project Dates:10/01/12 - 09/30/17

Project Title: "Sensorimotor Abnormalities in Childhood Onset Psychiatric Disorders"
Funding Agency: National Institutes of Health (NIH)/National Institute of Mental Health (NIMH)
Project Identifier: R01 MH081920
Description: The major goal of this project is to measure, using MEG and MRI, neurobiological deficits underlying motor coordination deficits in childhood onset schizophrenia and bipolar disorder.
Principal Investigator: Donald C. Rojas, PhD
Participating Division member: David B. Arciniegas, MD (Co-Investigator)
Project Dates: 06/01/09 - 05/31/14

Project Title: "Million Veteran Program (MVP): A Partnership with Veterans”
Funding Agency: Department of Veterans Affairs
Project Identifier: CSP-G002
Description: The goal of MVP is to partner with Veterans receiving their care in the VA Healthcare System to study how genes affect health.
Principal Investigator: Rayan K. Al Jurdi, MD (Houston Site)
Participating Division member: Rayan K. Al Jurdi, MD (Houston Site)
Project Dates: 06/03/11 - 06/03/18

Project Title: "Optimization of IV Ketamine for Treatment of Resistant Major Depression"
Funding Agency: National Institutes of Health (NIH)/National Institute of Mental Health (NIMH)
Project Identifier: R01 MH081870
Description: The major goal of this project is to measure the acute efficacy and safety of IV ketamine in treatment-resistant unipolar depression.
Principal Investigator: Sanjay Mathew, MD
Participating Division member: Rayan K. Al Jurdi, MD (Co-Investigator)
Project Dates: 07/23/09 – 04/30/14

Project Title: "2/3 - Efficacy and Tolerability of Riluzole in Treatment-Resistant Depression"
Funding Agency: National Institutes of Health (NIH)/National Institute of Mental Health (NIMH)
Project Identifier: R01 MH085054
Description: The major goal of this collaborative project is to evaluate the efficacy and safety of riluzole augmentation of the selective serotonin reuptake inhibitor citalopram in outpatients ages 18-65 with moderate treatment-resistant depression.
Principal Investigator: Sanjay Mathew, MD
Participating Division member: Rayan K. Al Jurdi, MD (Co-Investigator)
Project Dates: 08/01/10 – 04/30/14

Project Title: "Genetics of Functional Disability in Schizophrenia and Bipolar Illness"
Funding Agency: Department of Veterans Affairs
Project Identifier: CSP #572
Description: The purpose of this study is to detect genetic associations for the development of schizophrenia (SZ) and bipolar illness (BP) by comparing Veterans with these diseases to "psychiatrically healthy" Veterans from Veterans Health Administration medical centers.
Principal Investigator: Rayan K. Al Jurdi, MD
Participating Division member: Rayan K. Al Jurdi, MD (Principal Investigator)
Project Dates: 06/01/10 – 06/01/14

E-mail this page to a friend